mymedpharma limited Company Information
Company Number
05504955
Website
www.mymedpharma.comRegistered Address
mymed house, 95 -97 johnston street, blackburn, lancashire, BB2 1HY
Industry
Other human health activities
Telephone
-
Next Accounts Due
April 2024
Group Structure
View All
Shareholders
mymedpharma holdings ltd 100%
mymedpharma limited Estimated Valuation
The estimated valuation range for mymedpharma limited, derived from financial data as of March 2022 and the most recent industry multiples, is between £0 to £15.6k
mymedpharma limited Estimated Valuation
The estimated valuation range for mymedpharma limited, derived from financial data as of March 2022 and the most recent industry multiples, is between £0 to £15.6k
mymedpharma limited Estimated Valuation
The estimated valuation range for mymedpharma limited, derived from financial data as of March 2022 and the most recent industry multiples, is between £0 to £15.6k
Get a detailed valuation report, edit figures and unlock valuation multiples.
Mymedpharma Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Mymedpharma Limited Overview
Mymedpharma Limited is a dissolved company that was located in blackburn, BB2 1HY with a Companies House number of 05504955. It operated in the other human health activities sector, SIC Code 86900. Founded in July 2005, it's largest shareholder was mymedpharma holdings ltd with a 100% stake. The last turnover for Mymedpharma Limited was estimated at £42.8k.
Upgrade for unlimited company reports & a free credit check
Mymedpharma Limited Health Check
Pomanda's financial health check has awarded Mymedpharma Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 4 areas for improvement. Company Health Check FAQs
1 Strong
2 Regular
4 Weak
Size
annual sales of £42.8k, make it smaller than the average company (£738.2k)
- Mymedpharma Limited
£738.2k - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Mymedpharma Limited
- - Industry AVG
Production
with a gross margin of 20.4%, this company has a higher cost of product (35.6%)
- Mymedpharma Limited
35.6% - Industry AVG
Profitability
an operating margin of -82.3% make it less profitable than the average company (8.5%)
- Mymedpharma Limited
8.5% - Industry AVG
Employees
with 1 employees, this is below the industry average (19)
1 - Mymedpharma Limited
19 - Industry AVG
Pay Structure
on an average salary of £23.4k, the company has an equivalent pay structure (£23.4k)
- Mymedpharma Limited
£23.4k - Industry AVG
Efficiency
resulting in sales per employee of £42.8k, this is equally as efficient (£42.1k)
- Mymedpharma Limited
£42.1k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Mymedpharma Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 163 days, this is slower than average (16 days)
- Mymedpharma Limited
16 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Mymedpharma Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Mymedpharma Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Mymedpharma Limited
- - Industry AVG
mymedpharma limited Credit Report and Business Information
Mymedpharma Limited Competitor Analysis
Perform a competitor analysis for mymedpharma limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
mymedpharma limited Ownership
MYMEDPHARMA LIMITED group structure
Mymedpharma Limited has no subsidiary companies.
mymedpharma limited directors
Mymedpharma Limited currently has 2 directors. The longest serving directors include Mr Mujahid Ali (Jul 2005) and Mr Tabassam Zabier (Sep 2009).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Mujahid Ali | England | 44 years | Jul 2005 | - | Director |
Mr Tabassam Zabier | United Kingdom | 45 years | Sep 2009 | - | Director |
MYMEDPHARMA LIMITED financials
Mymedpharma Limited's latest turnover from March 2022 is estimated at £42.8 thousand and the company has net assets of -£15.2 thousand. According to their latest financial statements, Mymedpharma Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2022 | Mar 2021 | Mar 2020 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||
Other Income Or Grants | |||||||||||||
Cost Of Sales | |||||||||||||
Gross Profit | |||||||||||||
Admin Expenses | |||||||||||||
Operating Profit | |||||||||||||
Interest Payable | |||||||||||||
Interest Receivable | |||||||||||||
Pre-Tax Profit | |||||||||||||
Tax | |||||||||||||
Profit After Tax | |||||||||||||
Dividends Paid | |||||||||||||
Retained Profit | |||||||||||||
Employee Costs | |||||||||||||
Number Of Employees | 1 | 2 | 5 | 7 | 4 | ||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2022 | Mar 2021 | Mar 2020 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 0 | 34,825 | 43,668 | 61,375 | 78,489 | 99,503 | 126,387 | 80,427 | 69,479 | 65,632 | 83,468 | 87,296 | 760 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 0 | 34,825 | 43,668 | 61,375 | 78,489 | 99,503 | 126,387 | 80,427 | 69,479 | 65,632 | 83,468 | 87,296 | 760 |
Stock & work in progress | 0 | 0 | 0 | 57,293 | 69,430 | 62,100 | 70,260 | 64,785 | 59,250 | 32,091 | 9,628 | 0 | 0 |
Trade Debtors | 0 | 0 | 38,819 | 150,301 | 233,784 | 167,383 | 185,369 | 686,606 | 585,856 | 412,041 | 518,410 | 309,227 | 112,434 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 44,429 | 355,060 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 0 | 119 | 70,464 | 529,856 | 63,795 | 55,946 | 44,402 | 385,205 | 217,219 | 161,228 | 154,424 | 136,712 | 126,547 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 0 | 119 | 153,712 | 1,092,510 | 367,009 | 285,429 | 300,031 | 1,136,596 | 862,325 | 605,360 | 682,462 | 445,939 | 238,981 |
total assets | 0 | 34,944 | 197,380 | 1,153,885 | 445,498 | 384,932 | 426,418 | 1,217,023 | 931,804 | 670,992 | 765,930 | 533,235 | 239,741 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 15,222 | 14,972 | 92,677 | 372,269 | 192,872 | 419,411 | 410,467 | 1,144,060 | 825,409 | 531,211 | 605,173 | 356,117 | 177,822 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 75,730 | 778,906 | 286,945 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 15,222 | 14,972 | 168,407 | 1,151,175 | 479,817 | 419,411 | 410,467 | 1,144,060 | 825,409 | 531,211 | 605,173 | 356,117 | 177,822 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 12,861 | 12,861 | 10,083 | 10,297 | 12,798 | 13,844 | 144 |
total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 12,861 | 12,861 | 10,083 | 10,297 | 12,798 | 13,844 | 144 |
total liabilities | 15,222 | 14,972 | 168,407 | 1,151,175 | 479,817 | 419,411 | 423,328 | 1,156,921 | 835,492 | 541,508 | 617,971 | 369,961 | 177,966 |
net assets | -15,222 | 19,972 | 28,973 | 2,710 | -34,319 | -34,479 | 3,090 | 60,102 | 96,312 | 129,484 | 147,959 | 163,274 | 61,775 |
total shareholders funds | -15,222 | 19,972 | 28,973 | 2,710 | -34,319 | -34,479 | 3,090 | 60,102 | 96,312 | 129,484 | 147,959 | 163,274 | 61,775 |
Mar 2022 | Mar 2021 | Mar 2020 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||
Operating Profit | |||||||||||||
Depreciation | 6,635 | 8,843 | 19,242 | 17,114 | 26,884 | 34,502 | 23,667 | 20,487 | 19,026 | 24,316 | 24,030 | 190 | |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Tax | |||||||||||||
Stock | 0 | 0 | 0 | -12,137 | 7,330 | -8,160 | 5,475 | 5,535 | 27,159 | 22,463 | 9,628 | 0 | 0 |
Debtors | 0 | -83,248 | 83,248 | 271,577 | 66,401 | -17,986 | -501,237 | 100,750 | 173,815 | -106,369 | 209,183 | 196,793 | 112,434 |
Creditors | 250 | -77,705 | 92,677 | 179,397 | -226,539 | 8,944 | -733,593 | 318,651 | 294,198 | -73,962 | 249,056 | 178,295 | 177,822 |
Accruals and Deferred Income | 0 | -75,730 | 75,730 | 491,961 | 286,945 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | -12,861 | 0 | 2,778 | -214 | -2,501 | -1,046 | 13,700 | 144 |
Cash flow from operations | |||||||||||||
Investing Activities | |||||||||||||
capital expenditure | |||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||
Financing Activities | |||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||||
interest | |||||||||||||
cash flow from financing | |||||||||||||
cash and cash equivalents | |||||||||||||
cash | -119 | -70,345 | 70,464 | 466,061 | 7,849 | 11,544 | -340,803 | 167,986 | 55,991 | 6,804 | 17,712 | 10,165 | 126,547 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -119 | -70,345 | 70,464 | 466,061 | 7,849 | 11,544 | -340,803 | 167,986 | 55,991 | 6,804 | 17,712 | 10,165 | 126,547 |
P&L
March 2022turnover
42.8k
-30%
operating profit
-35.2k
0%
gross margin
20.4%
+7.57%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2022net assets
-15.2k
-1.76%
total assets
0
-1%
cash
0
-1%
net assets
Total assets minus all liabilities
mymedpharma limited company details
company number
05504955
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
July 2005
age
19
accounts
Unaudited Abridged
ultimate parent company
previous names
N/A
incorporated
UK
address
mymed house, 95 -97 johnston street, blackburn, lancashire, BB2 1HY
last accounts submitted
March 2022
mymedpharma limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to mymedpharma limited.
mymedpharma limited Companies House Filings - See Documents
date | description | view/download |
---|